Effects of different sufentanil target concentrations on the MACBAR of sevoflurane in patients with carbon dioxide pneumoperitoneum stimulus.

BACKGROUND: This study aims to observe the effects of different target controlled plasma sufentanil concentrations on the minimum alveolar concentration (MAC) of sevoflurane for blocking adrenergic response (BAR) in patients undergoing laparoscopic cholecystectomy with carbon dioxide pneumoperitoneum stimulation.
METHODS: Eighty-five patients undergoing laparoscopic cholecystectomy, aged 30-65 years, with American Society of Anesthesiologists physical status I-II, were enrolled in this study. All the patients were randomly divided into 5 groups (S0, S1, S2, S3, S4) with different sufentanil plasma target concentration (0.0, 0.1, 0.3, 0.5, 0.7 ng ml- 1). Anesthesia was induced by inhalation of 8% sevoflurane in 100% oxygen, and 0.6 mg kg- 1 of rocuronium was intravenously injected to facilitate the insertion of a laryngeal mask airway. The end-tidal sevoflurane concentration and sufentanil plasma target concentration were adjusted according to respective preset value in each group. The hemodynamic response to pneumoperitoneum stimulus was observed after the end-tidal sevoflurane concentration had been maintained stable at least for 15 min. The MACBAR of sevoflurane was measured by a sequential method. Meanwhile, epinephrine (E) and norepinephrine (NE) concentrations in the blood were also determined before and after pneumoperitoneum stimulus in each group.
RESULTS: When the method of independent paired reversals was used, the MACBAR of sevoflurane in groups S0, S1, S2, S3, S4 was 5.333% (confidence interval [CI] 95%: 5.197-5.469%), 4.533% (95% CI: 4.451-4.616%), 2.861% (95% CI: 2.752-2.981%), 2.233% (95% CI: 2.142-2.324%) and 2.139% (95% CI: 2.057-2.219%), respectively. Meanwhile, when the isotonic regression analysis was used, the MACBAR of sevoflurane in groups S0, S1, S2, S3, S4 was 5.329% (95% CI: 5.321-5.343%), 4.557% (95% CI: 4.552-4.568%), 2.900% (95% CI: 2.894-2.911%), 2.216% (95% CI: 2.173-2.223%) and 2.171% (95% CI: 2.165-2.183%), respectively. The MACBAR was not significantly different between groups S3 and S4 when using 0.5 and 0.7 ng ml- 1 of sufentanil plasma target concentrations. No significant difference was found in the change of E or NE concentration between before and after pneumoperitoneum stimulation in each group.
CONCLUSIONS: The MACBAR of sevoflurane can be decreased with increasing sufentanil plasma target concentrations. A ceiling effect of the decrease occurred at a sufentanil plasma target concentration of 0.5 ng ml- 1. When the sympathetic adrenergic response was inhibited in half of the patients to pneumoperitoneum stimulation in each group, the changes of E and NE concentrations showed no significant differences. TRIAL REGISTRATION: The study was registered at http://www.chictr.org.cn ( ChiCTR1800015819 , 23, April, 2018).

RCT Entities:   Population Interventions Outcomes

Background

With the development of minimally invasive techniques, laparoscopic surgery under inhalation anaesthesia has become increasing popular in general surgery [1-3]. However, inhalation anaesthetic used alone to provide all the necessary components of general anesthesia under laparoscopic surgery may increase the risk of cardiovascular inhibition and inhaled anaesthetic toxicity [4-6]. Many agents have been used to decrease the minimal alveolar concentration (MAC) of inhalation anaesthetics [7, 8]. Sufentanil, as an adjuvant, offers numerous advantages, including a reduced incidence of postoperative nausea and vomiting compared with the fentanyl [9], reduced opioid-induced hyperalgesia compared with the remifentanil [10], maintenance of stable hemodynamics, excellent analgesic effect. The MAC of sevoflurane for blocking the adrenergic response (BAR) at different sufentanil plasma target concentrations under laparoscopic pneumoperitoneum stimulus has not been reported. Therefore, our primary aim of this study is to observe the MACBAR of sevoflurane combined with different sufentanil plasma target concentrations in patients under carbon dioxide pneumoperitoneum stimulation. A secondary aim is to explore the concentrations of epinephrine and norepinephrine in the blood when the adrenergic response was inhibited in half of the patients.

Methods

Study design

The study was approved by the Ethics Committee of Affiliated Hospital of North Sichuan Medical College, Nanchong, China (Approved No. 2017/043). Written informed consents were obtained from all participants. All experiment procedures (blood collections and arterial catheterization) and data collection were conducted with prior informed consents. This study adhered to the applicable CONSORT guidelines and was registered with the Chinese Clinical Trials Registry at http://www.chictr.org.cn (ChiCTR1800015819, principal investigator: Yanxia Guo, date of registration: April 23, 2018).

The research was conducted between May 2018 and March 2019. Eighty five American Society of Anesthesiologists (ASA) physical status I-II, patients aged between 30 and 65 years, were randomly assigned to five groups (S0, S1, S2, S3, S4) according to a computer generated randomization. Patients in the five groups were anaesthetized by mask inhalation of sevoflurane and intravenous infusion of sufentanil with different plasma target concentrations: 0.0, 0.1, 0.3, 0.5, 0.7 ng ml− 1. Exclusion criteria included that: patients with a history of cardiovascular, lung, kidney or brain disease; long-term drug or alcohol abuse; recent take drugs known to affect the sympathetic adrenergic and cardiovascular systems; and body mass index (BMI) ≧30 kg m− 2. Withdrawal criteria included patients with mean arterial pressure (MAP) < 50 mmHg or heart rate (HR) < 50 bpm at any time during experimental observation; failing to achieve creation of the carbon dioxide pneumoperitoneum on the first attempt; or asking for adjustment of the pneumoperitoneal pressure above or below the preset value.

Anaesthesia administration

Induction

All patients were fasted at least for 8 h before surgery and without any preoperative medication. Before induction of anaesthesia, patient’s MAP, HR, electrocardiogram, and oxygen saturation were monitored as per routine with a PM-9000 express monitor (Mindray Medical International Limited, Shenzhen, China). Simultaneously, a peripheral intravenous catheter was inserted for infusion of Ringer’s solution at a rate of 10 ml kg− 1 h− 1. An arterial catheter was inserted into the left radial artery for monitoring patient’s arterial blood pressure and collecting blood samples. Anaesthesia was induced by inhalation of 8% sevoflurane with 100% oxygen until patients lost their consciousness, then 0.6 mg kg− 1 of rocuronium was intravenously injected to facilitate the insertion of laryngeal mask airway (Tuoren medical equipment group co. LTD, Henan, China) insertion. Then mechanical ventilation was begun using 100% oxygen with a tidal volume of 6 to 8 ml kg− 1. A normal end tidal carbon dioxide (CO2) tension (35 to 45 mmHg) was obtained by adjusting the respiratory frequency at 12 to 16 breaths min− 1. The end-tidal sevoflurane concentration and CO2 partial pressure were monitored continuously using the above-mentioned monitor. Depth of anaesthesia was monitored by the bispectral index (BIS) (Canwell Medical International Limited, Zejiang, China) which was placed before induction.

Measurement of MACBAR

After laryngeal mask airway insertion, sufentanil was administered by target-controlled infusion with Bovil pharmacokinetic model using a micro pump (TCI-I, ver 4.0, Guangxi VERYARK Technology Co., Ltd), and the plasma target concentration of sufentanil was 0.0, 0.1, 0.3, 0.5, 0.7 ng ml− 1 in groups S0, S1, S2, S3, S4, respectively. Simultaneously, the inhaled sevoflurane concentration was adjusted to obtain a stable preset end-tidal value according to our pilot study. In order to avoid a potential risk of intraoperative awareness, a higher initial end-tidal sevoflurane concentration was tested in the pilot study. The first patient in groups S0, S1, S2, S3 and S4 received a start end-tidal sevoflurane preset concentration of 5.0, 4.6, 3.0, 2.3 and 2.0% which was determined to be close to the MACBAR, respectively. An up-and-down sequential-allocation method was applied to determine the MACBAR of sevoflurane in each group as described in our previous studies [11, 12].

The CO2 pneumoperitoneum was created when the preset end-tidal sevoflurane concentration had been maintained stable at least 15 min. The creation of pneumoperitoneum was initiated using a Veress needle with the CO2 pressure set to 13 mmHg at umbilicus and the insufflation flow rate was set at 3 L/min. After the CO2 pneumoperitoneum had been created a 10-mm trocar replaced the Veress needle. Another 10-mm trocar and a 5-mm trocar were installed through a subxiphoid port and a port in the right subcostal area of the midclavicular line, respectively. HR and MAP were determined before induction, 3 and 1 min before CO2 pneumoperitoneum, and 1 and 3 min after three trocars were installed. Presence or absence of a sympathetic adrenergic response during the creation of the CO2 pneumoperitoneum was indicated by HR or MAP was recorded. Both the mean value of MAP and the mean value of HR measured 3 and 1 min before pneumoperitoneum stimulation were defined as the pre-pneumoperitoneum values, and the mean value of HR and the mean value of MAP measured 1 and 3 min after the trocars had been installed were defined as the post-pneumoperitoneum values. If the response was positive (an increase of patient’s HR or MAP > 20% of its pre-pneumoperitoneum value), the subsequent tested patient’s end-tidal sevoflurane concentration would be increased by 0.2%. If the response was absent i.e. HR and MAP change of < 20% of its pre-pneumoperitoneum value, the subsequent tested patient’s end-tidal sevoflurane concentration would be decreased by 0.2%. Patients with bradycardia (HR < 50 bpm) or hypotension (MAP < 50 mmHg) at any time during experimental observation were administered vascular active drugs such as atropine, ephedrine, and withdrawn from the study, a same tested end-tidal sevoflurane concentration was repeated in the following case. The study was continued until six crossing points of a negative versus positive response in the pre-and the next patient had occurred. The investigator responsible for recording the response of the patients to CO2 pneumoperitoneum was blinded to the plasma target controlled sufentanil concentrations and end-tidal sevoflurane concentration used in all the study patients. The MACBAR of sevoflurane in each group was calculated as the mean value of the end-tidal sevoflurane concentrations corresponding to the six crossing points.

After the above test was completed, the target controlled infusion of sufentanil was stopped in each group. The patients in group S0 received an i.v. bolus of 0.3 μg kg− 1 sufentanil. Furthermore, the inspired concentration of sevoflurane was adjusted to maintain the end-tidal concentrations at 1.4–1.7 MAC for maintaining the BIS value between 40 and 60. MAP was maintained between 60 and 85 mmHg intraoperatively. If the MAP increased by more than 20% compared with its preoperative value, a bolus of 10 μg sufentanil was administered. After surgery and removal of the laryngeal mask airway, patients were transported to the post- anaesthesia care unit (PACU). In the PACU, all patients were asked about whether there was any intraoperative awareness or not.

Analysis of blood samples

Arterial blood samples were collected 3 min before and after CO2 pneumoperitoneum and stored in sodium-heparin-containing tubes. Soon after, the plasma was separated and kept frozen at − 70 °C until analysis. The method used to measure the concentrations of E and NE in the current investigation have been described previously [12].

Statistical analysis

Statistical analysis was performed using SPSS 23.0 software. The MACBAR was estimated from the up-and-down sequences using the method of independent paired reversals, which enabled MACBAR with 95% CIs to be derived [13]. The sequences were also subjected to isotonic regression analyses. To compare the MACBAR from different groups more precisely, the 83% CIs were estimated using the isotonic regression analysis. The delta HR, delta MAP, delta E, delta NE value were calculated as the differences between their average values measured 1 and 3 min before and after CO2 pneumoperitoneum. The data are presented as mean (SDs or 95%CI). The preoperative data, including gender and ASA class were compared with X2 test. The preoperative data (age, BMI), the intraoperative data, the postoperative data, the MACBARS, the concentrations of E and NE, delta E, delta NE, MAP, delta MAP, HR, and delta HR were compared among the 5 groups using one-way analysis of variance (ANOVA). P value < 0.05 was considered as statistical significance.

Results

A total of 85 patients were recruited in this study. One case in group S0 and one case in group S3 both with MAP < 50 mmHg were removed from the study. Two cases with HR < 50 bpm in group S4 were also removed from the study. Ultimately, to obtain six crossing points, 14, 14, 18, 20 and 15 patients were used in groups S0-S4, respectively (Fig. 1), so that 81 patients completed the study. No significant differences were found in the patients’ preoperative data, operation time and rocuronium consumed among the 5 groups (Table 1). No intraoperative awareness was reported in the postoperative follow up.

Fig. 1

Dixon up-and-down plots for each group. The plasma target concentration of sufentanil in groups S0, S1, S2, S3 and S4 was 0.0, 0.1, 0.3, 0.5 and 0.7 ng ml− 1, respectively. The empty (solid) circle represents the negative (positive) reaction to hemodynamics parameters, and the triangle indicates the intersection of negative and positive reactions. The ninth patient was given the same concentration of sevoflurane both in group S2 and group S3. To get six crossovers, 14, 14, 18, 20 and 15 patients were needed in groups S0-S4, respectively

Table 1

Patients characteristics and Intraoperative and Postoperative data

Parameter	Group S0	Group S1	Group S2	Group S3	Group S4
Preoperative data
Gender (n, M/F)	6/8	6/8	6/12	10/10	7/8
ASA class (I/II)	7/7	6/8	10/8	10/10	8/7
Age (yr)	41 (8)	38 (9)	37 (10)	41 (11)	39 (9)
Body weight (kg)	68.3 (9.8)	65.7 (8.4)	67.2 (7.9)	66.2 (8.5)	67.3 (9.2)
BMI (kg m− 2)	23.1 (2.2)	23.4 (2.3)	23.1 (2.7)	23.6 (1.9)	24.0 (2.3)
MAP (mmHg)	92.8 (9.6)	89.8 (6.9)	91.2 (6.7)	89.2 (8.2)	89.9 (9.6)
HR (bpm)	82 (10)	77 (12)	82 (10)	83 (9)	78 (12)
Intraoperative data
Operation time (min)	62.3 (7.9)	59.6 (8.1)	60.7 (8.9)	56.5 (9.2)	58.9 (5.0)
Total sufentanil consumed dose (μg)	31.4 (5.6)	29.8 (3.9)	30.3 (4.5)	44.6 (5.8)*	61.4 (4.8)*#
Rocuronium consumed dose (mg)	35.0 (5.0)	37.5 (6.3)	36.7 (4.9)	38.3 (4.6)	38.6 (6.2)
Postoperative data
Spontaneous breathing recovery time (min)	5.2 (2.1)	4.8 (2.5)	5.0 (1.9)	4.5 (2.8)	10.0 (3.9)#
Eye opening time (min)	7.8 (3.1)	8.0 (1.9)	7.5 (1.8)	8.2 (3.3)	16.4 (5.2)#
Extubation time (min)	10.2 (1.7)	11.7 (2.3)	10.5 (1.7)	11.0 (3.0)	20.2 (3.8)#

Data are presented as mean (SD)

*P < 0.05 vs. the value of group S0, S1, S2, respectively. #P < 0.05 vs. the value of S0, S1, S2, S3, respectively

The estimates of MACBAR of sevoflurane by the method of independent paired reversals and isotonic regression using the different plasma target concentration of sufentanil in groups S0-S4 are shown in Table 2. The 83% CIs were overlapped in group S3 and S4 using the isotonic regression analysis. For both methods, the MACBAR was not significantly different between group S3 and group S4 when using 0.5 and 0.7 ng ml− 1 of sufentanil plasma target concentrations. The HR and delta HR were similar among groups S2, S3, and S4, but significantly lower than groups S0 and S1 (P < 0.05, Table 3). No significant differences were found in the MAP, delta MAP, epinephrine and norepinephrine concentration, delta epinephrine and norepinephrine concentration among the 5 groups (Table 3). The total administered dose of sufentanil in both group S3 and group S4 was higher than in groups S0, S1, S2 (P < 0.05, Table 1). The spontaneous breathing recovery time, eye opening time and extubation time in group S4 was longer than those in the other 4 groups (P < 0.05, Table 1).

Table 2

The MACBAR of sevoflurane using the method of independent paired reversals and isotonic regression analyses in 5 groups

Group	Target concentrationof sufentanil (ng ml−1)	Empirical mean MACBAR(95% CI)	Isotonic regression MACBAR(95% CI), (83% CI)
S0	0.0	5.333 (5.197–5.469)	5.329 (5.321–5.343) (5.324–5.339)
S1	0.1	4.533 (4.451–4.616)*	4.557 (4.552–4.568) (4.555–4.566)
S2	0.3	2.861 (2.752–2.981)*#	2.900 (2.894–2.911) (2.898–2.909)
S3	0.5	2.233 (2.142–2.324)*#※	2.216 (2.173–2.223) (2.177–2.212)
S4	0.7	2.139 (2.057–2.219)*#※	2.171 (2.165–2.183) (2.170–2.180)

The data of MACBAR were presented as means (95% CI or 83% CI)

*P < 0.05 vs. value of group S0. #P < 0.05 vs. value of group S1.※P < 0.05 vs. value of group S2

Table 3

The comparison of MAP, HR, epinephrine and norepinephrine concentrations before and after pneumoperitoneum stimulus among 5 groups

	Group S0	Group S1	Group S2	Group S3	Group S4
MAP (mmHg)
Before pneumoperitoneum	63 (5)	62 (4)	64 (4)	63 (5)	62 (5)
After pneumoperitoneum	78 (8)	75 (8)	79 (8)	78 (7)	76 (6)
Delta	15 (7)	13 (8)	15 (6)	16 (2)	14 (8)
HR (bpm)
Before pneumoperitoneum	89 (11)	82 (15)	67 (6)*#	61 (5)*#	62 (6)*#
After pneumoperitoneum	100 (13)	92 (15)	69 (7)*#	64 (8)*#	66 (6)*#
Delta	11 (5)	10 (4)	2 (1)*#	3 (1)*#	3 (2)*#
Epinephrine (ng ml−1)
Before pneumoperitoneum	2.85 (0.23)	2.97 (0.19)	2.92 (0.19)	2.82 (0.28)	2.67 (0.18)
After pneumoperitoneum	2.92 (0.25)	3.04 (0.40)	2.91 (0.17)	2.85 (0.29)	2.62 (0.11)
Delta	0.07 (0.04)	0.07 (0.02)	0.03 (0.02)	0.03 (0.01)	−0.04 (0.03)
Norepinephrine (ng ml− 1)
Before pneumoperitoneum	3.23 (0.21)	3.63 (0.23)	2.89 (0.19)	3.18 (0.95)	3.12 (0.74)
After pneumoperitoneum	3.11 (0.33)	3.55 (0.13)	2.81 (0.25)	3.15 (0.65)	3.07 (0.45)
Delta	−0.12 (0.07)	− 0.08 (0.04)	− 0.08 (0.05)	−0.03 (0.02)	− 0.05 (0.03)

The value of each parameter before pneumoperitoneum was the average value measured 3 and 1 min before CO2 pneumoperitoneum. The value of each parameter after pneumoperitoneum was the average value measured 3 and 1 min after CO2 pneumoperitoneum and the delta value of each parameter was the difference between the average value measured 1 and 3 min after CO2 pneumoperitoneum and before CO2 pneumoperitoneum value

*P < 0.05 vs. values of group S0. #P < 0.05 vs. values of group S1

Discussion

The results of this study indicate that the reduction of the MACBAR of sevoflurane by sufentanil is dose-dependent. The overlapped 83% CIs in group S3 and S4 using the isotonic regression analysis indicate the MACBAR had no significant difference when using 0.5 and 0.7 ng ml− 1 of sufentanil plasma target concentrations. This suggests that a ceiling effect of the decrease of MACBAR of sevoflurane occurred when the sufentanil plasma target concentration increased to > 0.5 ng ml− 1 (Table 2). This ceiling effect of sufentanil is similar to the result measured by Brunner and colleagues [14] at the same plasma target concentration when they evaluated the reduction of isoflurane’s MAC by sufentanil in response to skin incision. Sufentanil is a μ receptor agonist, which can be saturated when its plasma target concentration is beyond a certain level [15]. We speculate that a similar ceiling effect will occur under a similar plasma target concentration of sufentanil no matter what kind of surgery or stimulus is selected. The ceiling plasma concentration of sufentanil (0.18 ng ml− 1) in Shun-Huang and colleague’s study [16] is significantly lower than that of our experiment result. We believe that is reasonably explained by the concomitant administration of 60% nitrous oxide [17, 18]. Several studies show that nitrous oxide can combine with the μ receptor and decrease the available binding sites of sufentanil in humans [19-23].

In this study, the MACBAR of sevoflurane (5.333%) under laparoscopic pneumoperitoneum stimulation is higher than that measured by Katoh and his colleagues (4.15%) under skin incision [24]. It suggests that the laparoscopic pneumoperitoneum stimulus is stronger than the skin incision stimulus, so that a higher concentration of sevoflurane is needed to inhibit the stress reaction in laparoscopic surgery, which is consistent with the results of our previous study [25]. The MACBAR of sevoflurane measured in this study is also significantly higher than the value (4.6%) reported in our previous study in gynecologic patients [12]. Although the same CO2 pneumoperitoneum stimulus was used, the MACBAR of sevoflurane could also be affected by the location of the perforation for establishing pneumoperitoneum, the patient’s age and gender [26, 27], the methods of measurement [25, 26] and the criterion of judgment for a positive or negative response [27, 28]. Dixon thought that the MACBAR values could be estimated as the mean of four independent crossovers of responses [28]. Paul and his colleagues thought that the reliability of the Dixon method increased with the number of pairs and six pairs was enough [29]. An increase of 15% or more from the baseline value of MAP or HR was taken as the criterion of a positive response in many studies [8, 30]. However, in clinic, the fluctuation of MAP or HR within the range of 20% is also acceptable and reasonable. Therefore, in our current study, an increase of 20% or more from pre-pneumoperitoneum stimulation values of MAP or HR was taken as the standard to judge a positive response.

Our results indicated the delta E or NE concentrations did not differ among all 5 groups (Table 3). This observation implies that when the sympathetic adrenergic response was inhibited in half patients to pneumoperitoneum stimulation in each group, the change of E or NE concentration would be similar, no matter the target controlled sufentanil concentration and the end tidal sevoflurane concentration. Our results also showed patients’ HR could be depressed to some degree with the increase of sufentanil plasma target concentration (Table 3). However, the decrease in HR did not result in a decrease of patients’ MAP, especially when a high concentration of sufentanil was administrated. It implies the hemodynamic safety range of sufentanil is large, which is consistent with the results of Fechner and his colleagues [31]. Our study did show that the use of sufentanil at a large dose results in a delay of anaesthesia recovery (Table 1). Therefore, the administration of larger dose sufentanil for short surgery such as laparoscopic cholecystectomy is not recommended.

There are several potential limitations to our study. First, we did not measure arterial blood gases during the pneumoperitoneum period. Although the end-expiratory CO2 partial pressure was maintained in the normal range by adjusting the ventilator, we did not measure the actual CO2 partial pressure to exclude the influence of hypercarbia on the sympathetic adrenergic response. Second, we did not measure the actual plasma sufentanil concentration. Although the Bovill pharmacokinetic model for target-controlled infusion has been shown to be safe in Asian people, it would have been desirable to measure the actual plasma sufentanil concentration to exclude individual error. Third, we did not monitor muscle relaxation. The level of neuromuscular blockade may influence the relaxation of the abdominal muscles, so as to affect the ease of creation of the pneumoperitoneum and thereby affect the adrenergic response during CO2 insufflation.

Conclusions

The MACBAR of sevoflurane can be decreased with increasing sufentanil plasma target concentrations. A ceiling effect of the decrease occurred at a sufentanil plasma target concentration of 0.5 ng ml− 1. When the sympathetic adrenergic response was inhibited in half patients to pneumoperitoneum stimulation in each group, the changes of E and NE concentrations showed no significant differences.